Phase I/Ii Clinical Trial to Assess Safety and Efficacy of Intratumoral and Subcutaneous Injection of HVJ-E in Castration-Resistant Prostate Cancer Patients
Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2017.15
Full Text
Open PDFAbstract
Available in full text
Date
May 12, 2017
Authors
Publisher
Springer Science and Business Media LLC